enrylaze
jazz pharmaceuticals ireland limited - crisantaspase - prekursorko-lümfoblastne leukeemia-lümfoom - antineoplastilised ained - enrylaze is indicated as a component of a multi-agent chemotherapeutic regimen for the treatment of acute lymphoblastic leukaemia (all) and lymphoblastic lymphoma (lbl) in adult and paediatric patients (1 month and older) who developed hypersensitivity or silent inactivation to e. coli-derived asparaginase.
crisantaspase porton biopharma süste-/infusioonilahuse pulber
almac pharma services limited - asparaginaas - süste-/infusioonilahuse pulber - 10000tÜ 5tk